管桥医疗完成数千万元A轮融资，董事长马立金控股32%

Core Viewpoint - Beijing Guanqiao Medical Technology Co., Ltd. has completed a Series A financing round amounting to several tens of millions of yuan, primarily funded by the Beijing Pharmaceutical Health Industry Investment Fund, with continued support from existing shareholders [1] Group 1: Financing Details - The financing will be primarily used for research and development investments to promote new product development and technological breakthroughs [1] - The company aims to expand production scale, enhance capacity, and improve supply chain efficiency with the new funds [1] - There are plans for overseas market expansion and sales network development, including international registration and compliance [1] Group 2: Company Background - Guanqiao Medical was established in May 2020, with a registered capital of 5.4812 million yuan, focusing on high-end medical consumables [1] - The company has successfully obtained 8 domestic medical device registration certificates and has commercialized its pulmonary artery thrombectomy stent system [1] - The actual controller of the company is Ma Lijin, who holds a 31.51% stake and serves as the chairman and manager [1]